Teva Pharmaceutical Industries Ltd

IL

TEVA

Health Care

12.88 ₽

Current price

Strong sell
12.88 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    896 / 1328

  • Position in country

    525 / 777

  • Return on Assets, %

    -1.5

    -2.7

  • Net income margin, %

    9.6

    2.8

  • EBITDA margin, %

    36.9

    10.8

  • Debt to Equity, %

    264.2

    19.2

  • Intangible assets and goodwill, %

    51.8

    3.6

  • Revenue CAGR 3Y, %

    -1.7

    8.5

  • Total Equity change 1Y, %

    -3.9

    0

  • Revenue Y, % chg

    6.1

    0.5

  • P/BV

    1.9

    1.5

  • P/S

    0.9

    2.3

  • EV/S

    2

    2.4

  • EV/EBITDA

    6.8

    7.4

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    24

    51.3

  • Forward P/E

    5.3

    15.6

  • Expected dividend per share

    0

    0

Get an analytical review of this company

Competitors

Ranks

  • Novo Nordisk A/S

    00%

  • AstraZeneca PLC

    00%

  • Eli Lilly and Co

    00%

  • Roche Holding AG

    00%

  • Novartis AG

    00%

  • Taro Pharmaceutical Industries Ltd

    00%

  • Johnson & Johnson

    00%

  • Teva Pharmaceutical Industries Ltd

    00%

  • Merck & Co Inc

    00%

  • Pfizer Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Israel

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    15624.3

  • Ticker

    TEVA.N

  • ISIN

    US8816242098

  • IPO date

    1951-01-01

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-02-12

  • Date fact. publication of reports

    2023-12-31

Company Description

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: